Medical Device Contract Manufacturing
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
72
NCT05328557
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 9, 2021
Completion: Aug 3, 2022
NCT05866861
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus
Start: Apr 24, 2023
Completion: Apr 1, 2025
Loading map...